Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular
Free webinar: Telepathology: is there added value in LMICs?
Free webinar: Telepathology: is there added value in LMICs?

Brentuximab vedotin in the frontline setting

Dr Stephen Ansell - Mayo Clinic, Rochester, USA
Brentuximab vedotin in the frontline setting ( Dr Stephen Ansell - Mayo Clinic, Rochester, USA )
2 Jun 2013

Comment on biennial visual inspection with acetic acid (VIA), or vinegar

Prof Krishnansu Sujata Tewari - University of California Irvine, Orange, USA
Comment on biennial visual inspection with acetic acid (VIA), or vinegar ( Prof Krishnansu Sujata Tewari - University of California Irvine, Orange, USA )
2 Jun 2013

Effects of The Cancer Genome Atlas

Dr Matthew Ellis - Washington University in St Louis, USA
Effects of The Cancer Genome Atlas ( Dr Matthew Ellis - Washington University in St Louis, USA )
2 Jun 2013

AMAROS trial: radiotherapy versus lymph node dissection in breast cancer

Dr Robert Mansel - Cardiff University, UK
AMAROS trial: radiotherapy versus lymph node dissection in breast cancer ( Dr Robert Mansel - Cardiff University, UK )
2 Jun 2013

Lapatinib in combination with chemotherapy in breast cancer

Dr J. Randolph Hecht - UCLA Medical Center, Santa Monica, USA
Lapatinib in combination with chemotherapy in breast cancer ( Dr J. Randolph Hecht - UCLA Medical Center, Santa Monica, USA )
2 Jun 2013

Cetuximab superior to bevacizumab for advanced colorectal cancer

Dr Volke Heinemann - University of Munich Munich, Germany
Cetuximab superior to bevacizumab for advanced colorectal cancer ( Dr Volke Heinemann - University of Munich Munich, Germany )
1 Jun 2013

Improving outcomes of childhood neuroblastoma

Dr Garrett Brodeur - Cancer Center at The Children’s Hospital of Philadelphia, USA
Improving outcomes of childhood neuroblastoma ( Dr Garrett Brodeur - Cancer Center at The Children’s Hospital of Philadelphia, USA )
1 Jun 2013

Nivolumab produces long-lasting responses in patients with stage IV melanoma

Dr Mario Sznol - Yale Cancer Center, New Haven, USA
Nivolumab produces long-lasting responses in patients with stage IV melanoma ( Dr Mario Sznol - Yale Cancer Center, New Haven, USA )
1 Jun 2013

Delayed relapse of advanced ovarian cancer when treating with pazopanib

Dr Andreas du Bois - Kliniken Essen Mitte, Essen, Germany
Delayed relapse of advanced ovarian cancer when treating with pazopanib ( Dr Andreas du Bois - Kliniken Essen Mitte, Essen, Germany )
1 Jun 2013

Cetuximab superior to bevacizumab for advanced colorectal cancer

Dr Volker Heinemann - University of Munich, Germany
Cetuximab superior to bevacizumab for advanced colorectal cancer ( Dr Volker Heinemann - University of Munich, Germany )
1 Jun 2013

Spouses of patients with HPV-positive oropharyngeal cancer do not have increased oral HPV infections

Dr Gypsyamber D’Souza - Johns Hopkins Bloomberg School of Public Health, Baltimore, USA
Spouses of patients with HPV-positive oropharyngeal cancer do not have increased oral HPV infections ( Dr Gypsyamber D’Souza - Johns Hopkins Bloomberg School of Public Health, Baltimore, USA )
1 Jun 2013

New MEK inhibitor selumetinib is the first effective drug for advanced melanoma of the eye

Dr Richard D. Carvajal - Memorial Sloan-Kettering Cancer Center, New York, USA
New MEK inhibitor selumetinib is the first effective drug for advanced melanoma of the eye ( Dr Richard D. Carvajal - Memorial Sloan-Kettering Cancer Center, New York, USA )
1 Jun 2013

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation